Caroline Palomeque

David Stubbs

Hartaj Singh

Jason McCarthy

Kumar Raja

Ren Benjamin

Susan Lee

- SELLAS has significantly **strengthened its balance sheet** with **$31 million in gross proceeds** from warrant exercises this week, in addition to nearly **$24 million** last month, to support its clinical programs.  **[0001390478_2211889_1]** **[0001390478_2211889_26]** **[0001390478_2211889_27]** 
- The **Phase 3 RIGEL trial for GPS** (Galinpepimut-S) in AML is nearing a key milestone, with the **80th event expected by year-end 2025**.  **[0001390478_2211889_2]**  The trial has observed unexpectedly long survival times, which is considered an encouraging sign for the potential efficacy of GPS as a first-in-class maintenance therapy.  **[0001390478_2211889_2]** **[0001390478_2211889_15]** 
- SELLAS plans to advance its **SLS009 (Tebonciclib) program into the frontline setting for newly diagnosed AML patients** and those refractory to venetoclax and azacitidine by **Q1 2026**, with **initial data anticipated later that year**.  **[0001390478_2211889_3]**  This follows promising Phase 1/2 data showing improved median overall survival to **8-9 months** in venetoclax-refractory patients.  **[0001390478_2211889_6]**

SELLAS Provides Update on GPS and SLS009 Clinical Programs and Financing

- **SELLAS Life Sciences Group** announced the immediate exercise of existing warrants by an institutional investor, generating approximately **$31.0 million** in gross cash proceeds.  **[1390478_0001104659-25-102345_tm2529505d1_ex99-1.htm:0]** **[1390478_0001104659-25-102345_tm2529505d1_8k.htm:1]** 
- The exercised warrants, originally issued in **March and August 2024**, allowed for the purchase of up to **22,363,714 shares** of common stock.  **[1390478_0001104659-25-102345_tm2529505d1_ex99-1.htm:0]** **[1390478_0001104659-25-102345_tm2529505d1_8k.htm:1]** 
- In consideration for the exercise, the investor will receive new registered warrants to purchase an equivalent number of shares (**22,363,714**) at an exercise price of **$2.00** per share, exercisable immediately and expiring in **five years**.  **[1390478_0001104659-25-102345_tm2529505d1_ex99-1.htm:0]** **[1390478_0001104659-25-102345_tm2529505d1_8k.htm:1]** **[1390478_0001104659-25-102345_tm2529505d1_ex10-1.htm:2]** 
- The closing of this transaction is expected to occur on or about **October 28, 2025**.  **[1390478_0001104659-25-102345_tm2529505d1_ex99-1.htm:0]** 
- The company will pay financial advisors an aggregate fee of **5.75%** of the gross proceeds and reimburse legal expenses up to **$60,000**.  **[1390478_0001104659-25-102345_tm2529505d1_8k.htm:1]**

SELLAS Life Sciences Group Announces Exercise of Warrants for $31 Million Gross Proceeds

- SELLAS Life Sciences Group announced the **immediate exercise of existing warrants**, previously issued in March and August 2024, to purchase up to **22,363,714 shares** of its common stock.  **[1390478_2dad28c624aa438cb78803a84a7f25d6_0]** 
- This transaction is expected to generate approximately **$31.0 million** in gross cash proceeds for the company.  **[1390478_2dad28c624aa438cb78803a84a7f25d6_0]** 
- In consideration for the immediate exercise, the investor will receive new registered warrants to purchase up to **22,363,714 shares** of common stock at an exercise price of **$2.00**, which will be exercisable immediately and expire five years from the date of issuance.  **[1390478_2dad28c624aa438cb78803a84a7f25d6_0]** 
- The closing of this transaction is expected to occur on or about **October 28, 2025**.  **[1390478_2dad28c624aa438cb78803a84a7f25d6_0]**

SELLAS Life Sciences Group Announces Warrant Exercise and Gross Proceeds

- **Red Sea Global (RSG)** announced the **imminent opening** of the first resorts and attractions on **Shura Island** in **September**, including the SLS, EDITION, and InterContinental hotels.  **[1390478_5e1c61ba700b448883660fd3111b4587_0]** 
- The initial phase also features the debut of **Shura Links**, Saudi Arabia's first island golf course.  **[1390478_5e1c61ba700b448883660fd3111b4587_0]** **[1390478_5e1c61ba700b448883660fd3111b4587_1]** 
- Shura Island is planned to host **11 international standard resorts** in total, with the first exclusive residences available for delivery by the **end of 2025**.  **[1390478_5e1c61ba700b448883660fd3111b4587_0]** **[1390478_5e1c61ba700b448883660fd3111b4587_1]** 
- This initiative is a core component of Saudi Arabia's **Vision 2030** for economic diversification and is projected to create **120,000 new jobs**.  **[1390478_5e1c61ba700b448883660fd3111b4587_0]** **[1390478_5e1c61ba700b448883660fd3111b4587_2]**

Red Sea Global Announces Shura Island Resorts and Golf Course Opening

- Red Sea Global (RSG) announced that the first resorts and attractions on **Shura Island** will begin opening to guests in the **coming weeks**, with **Shura Links**, Saudi Arabia’s first island golf course, also set to open in **September**.  **[1390478_6654a4c431224e15920618d76302d063_0]** **[1390478_6654a4c431224e15920618d76302d063_1]** 
- Phase one of the launch includes the debut of **SLS, EDITION, and InterContinental hotels**.  **[1390478_6654a4c431224e15920618d76302d063_0]** 
- Shura Island is planned to eventually host **11 world-class resorts**, all scheduled to open over the next few months.  **[1390478_6654a4c431224e15920618d76302d063_0]** 
- The first exclusive homes on Shura Island, announced earlier this year, are expected to be ready for handover at the **end of 2025**.  **[1390478_6654a4c431224e15920618d76302d063_1]**

SELLAS Life Sciences Group (SLS)